Introduction
Towards the end of 2006, the Minister of State for Health established a Taskforce to review current organ donation arrangements in the UK. The Taskforce was invited to consider ways in which the number of cadaveric organ donors could be increased within existing legal frameworks. The Taskforce is chaired by Elisabeth Buggins, chair of NHS West Midlands Strategic Health Authority, and comprises intensive care clinicians and clinicians working in the field of organ procurement and transplantation, senior NHS managers, healthcare economists, bio-ethicists and representatives from the Department of Health for England and Northern Ireland and the devolved Assemblies in Scotland and Wales.
The need for change
Organ donation rates in the UK are amongst the lowest in Europe (Figure 1 ) 1 with the rate of 12.8 cadaveric donors per million of population per year being almost three times lower than that in Spain and half that in Italy, Austria and the USA. This has led to an inevitable and widening gap between the supply of cadaveric donors, which at best is static, and the demand for solid organ transplants which, despite artificial restrictions on access to waiting lists, continues to rise year on year (Figure 2) . 2 There are currently more than 8,000 people in the UK waiting for a transplant but only 3,000 transplants are carried out each year. More than 1,000 people die each year whilst awaiting a transplant. Live related-donor programmes have provided a partial solution for kidney and liver transplantation but there are no such options for those awaiting heart and lung transplantation. Furthermore, the risk of death for a living kidney donor is about 1 in 3,000 and up to 1 in 100 for living liver donation. The fact that living donors are willing to put their own lives at risk in order to save or improve that of a loved one, brings into sharp focus the stark reality of the shortage of cadaveric organs. Notwithstanding increases in living donation rates, it is donation after death confirmed by neurological criteria (brainstem death) that provides organs for virtually all heart and lung transplants, the overwhelming majority of liver transplants and many kidney transplants. These patients are typically being cared for in intensive care units and the recommendations of the Taskforce therefore have particular relevance to those working in intensive care.
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Organ donation rates in the UK are amongst the lowest in Europe and there is a widening gap between the supply of cadaveric organ donors and the demand for solid organ transplants. The Report from the Organ Donation Taskforce has recently been published and its 14 recommendations represent a structured and systematic approach to organ donation in the UK. The proposed changes will ensure that organ donation is considered every time a potential organ donor dies, that the wishes of the potential organ donor or their family are ascertained and respected, and that every opportunity is taken to maximise the number of organs that can be transplanted successfully. Clarification of legal and ethical issues will allow clinicians to embrace these changes with confidence. Taken together, the recommendations will deliver the organ donation service that is so urgently needed in the UK. 3 This retrospective review of case notes by local donor transplant co-ordinators (DTCs), sometimes weeks after death and with or without the recollections of clinical staff, limits the quality of the data. However, the following broad conclusions can be drawn from the PDA: 1. Diagnosed brainstem death is relatively uncommon, accounting for only 6% of all deaths on intensive care units. 2. In 15% of cases of diagnosed brainstem death in patients with no absolute medical contraindication to organ donation, there is no record that the attending clinicians considered the possibility of organ donation, or raised such a possibility with the patient' s next of kin. 3. The overall family refusal rate remains at around 40%, but only 10% of families who refuse to authorise donation do so because this was the stated wish of their relative. The family refusal rate in some black and minority ethnic groups approaches 80% and this is of particular concern because of the higher incidence of end-stage renal failure in such patient groups. 4. There is also a significant cohort of patients -perhaps as many as 600 patients each year -dying a cardiac death on intensive care units in whom a diagnosis of brainstem death was, in the opinion of the DTCs conducting the audit, likely but never confirmed.
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Recently the scope of the PDA has been extended to include the potential for organ donation after cardiac death, often referred to as controlled non-heart beating organ donation (NHBOD). This option for donation is available to some patients following withdrawal of active treatment including cardiorespiratory support, when it has been decided that further treatment options are unavailable or inappropriate. Despite the limited quality of the data from the PDA on this issue there is some evidence that there could be a substantial increase in the number of asystolic organ donors, and thereby in the number of cadaveric kidneys, livers and possibly lungs available for transplantation, were the programmes currently running in the minority of intensive care units that support controlled NHBOD adopted by the majority that do not.
Recommendations of the Taskforce
In order to address the endemic problems with organ donation in the UK, the key issues addressed by the Taskforce included: • The infrastructure underlying organ donor identification • Organ retrieval and transplant services • Legal and ethical obstacles to donation • The cost-effectiveness of transplantation • Training.
The Taskforce took evidence from clinicians who had led successful initiatives to improve donation rates elsewhere in the world, specifically Frank Delmonico, Professor of Surgery at Harvard Medical School, USA and Rafael Matesanz, Director of Organización Nacional de Transplantes, Spain. Whilst the achievements of the programmes in the USA and Spain are impressive, there was an overwhelming view that the Taskforce' s recommendations must be a bespoke solution for the UK rather than an ad hoc adoption of processes that have been developed to suit different healthcare environments.
The Taskforce Report was published on 16 January 2008 4 and states that a 50% increase in organ donation after death is possible and achievable within five years if all of its 14 recommendations are implemented throughout the UK. This increase is dependent on three key issues which have been highlighted by the Taskforce as being barriers to organ donation: • Donor identification and referral • Donor coordination • Organ retrieval arrangements.
Addressing these issues does not require any radical change in clinical practice, but rather a widespread application of current best practice -every day and everywhere. Across these three general categories are a number of other matters that also require urgent attention, in particular clarification of outstanding legal and ethical issues.
A UK-wide organ donation organisation
Although organ donation is a 'local' activity, transplantation can only be undertaken successfully as an integrated UK-wide service. It is for this reason that the Taskforce recommends that a UK-wide organ donation organisation (ODO) should be established and that the responsibility for its establishment should lie with NHSBT.
Clarification of legal, ethical and professional issues
The Taskforce was acutely aware of the crucial role that critical care clinicians play in the identification and management of potential organ donors. Substantial and moving evidence was received regarding the individual vulnerability that some clinicians feel when faced with what can be some of the most challenging issues in intensive care. It was also clear that there can be no substantial improvement in deceased organ donation in the UK until there is an authoritative and binding clarification of the ethical and legal issues that, real or otherwise, are seen by clinicians to prohibit the identification of more donors. Clinicians require reassurance that their actions in relation to organ donation do not present them with a conflict of interest and that they are clearly lawful. Therefore, one of the major recommendations of the Taskforce is that the outstanding legal, ethical and professional issues should be urgently resolved in order to ensure that clinicians are supported and able to work within a clear and unambiguous framework of good practice. The main issues centre on what measures a doctor could or should take in order to facilitate organ donation from a patient who is dying but not yet dead.
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These are relevant not only to all aspects of controlled NHBOD, 5 but also to certain aspects of death by neurological criteria. For example, there is a wide range of opinion on the probity of transferring a patient with a devastating intracranial catastrophe from an accident and emergency department to an intensive care unit, in order to perform brainstem death tests and maintain the potential for heart beating donation, or on the early referral to the donor transplant co-ordinator of a patient in whom brainstem death testing is likely to be performed in the near future.
Making organ donation usual not unusual
The striking feature of the successful initiatives in Spain, Italy and the USA is that deceased organ donation has become core business for all clinicians, their employing institutions, organ transplantation agencies and national departments of health. The Taskforce wishes to see similar arrangements in the UK and recommends the establishment of partnerships between clinicians and the hospitals in which they work, UK Transplant and its parent body NHSBT, and the Department of Health, with the roles and responsibilities of each being clearly defined and adequately resourced (Figure 3 ). In this way, all parts of the NHS can begin to embrace organ donation as a usual, not unusual event, and local policies, constructed around national guidelines, should be put in place to help achieve this. Importantly, discussion about organ donation should become, when appropriate, a routine part of all end-of-life care.
Monitoring organ donation
Organ donation has normally only been measured in terms of the number of actual donors, but an additional and important measure is the conversion rate, i.e. the proportion of potential donors who are identified and whose personal wishes, or those of their family, are both ascertained and fulfilled. Each stage of the process is currently measured through the PDA and this audit is being enhanced, expanded and converted into one that is web-based with real-time data input. The Taskforce recommends that the identification of potential organ donors and their notification to the ODO should be in response to defined criteria that identify, at the appropriate stage, all patients whose death is expected. In consultation with the Intensive Care Society, a model to ensure comprehensive potential donor identification was developed. The Taskforce endorsed the following proposals for a national protocol for the notification of potential organ donors:
• When no further treatment options are available or appropriate, and there is a plan to confirm death by neurological criteria, the DTC should be notified as soon as sedation/analgesia is discontinued, or immediately if the patient has never received sedation/analgesia. This notification should take place even if the attending clinical staff believes that donation after death confirmed by neurological criteria might be contraindicated or inappropriate. • In the context of catastrophic neurological injury, when no further treatment options are available or appropriate and there is no intention to confirm death by neurological criteria, the DTC should be notified when a decision has been made by a consultant to withdraw active treatment and this has been recorded in a dated, timed and signed entry in the case notes. This notification should take place even if the attending clinical staff believes that death cannot be diagnosed by neurological criteria or that donation after cardiac death might be contraindicated or inappropriate. Whilst the Taskforce was impressed with the various oversight and notification systems, including clinical referral 'triggers,' that have been introduced in a number of other countries, particularly the USA, it was agreed that these would not easily translate into UK practice. In particular, the Taskforce was sensitive to the expressed concerns of professional colleagues within intensive care medicine that the introduction of clinical triggers at this stage would be counterproductive and that, for many intensive care clinicians, the minimum criteria for identification and notification outlined above represent a substantial shift in practice. The Taskforce stresses that these notification criteria should not be seen in isolation, but as part of the overall strategy, with a number of components that, taken together, will ensure that all potential donors are identified and referred.
Brain stem testing
The Taskforce was mindful of the evidence from the PDA identifying significant numbers of patients dying a cardiac death on intensive care units in whom a diagnosis of brainstem death was likely but never confirmed. The reasons for not performing brainstem death tests under such circumstances appear to include cardiovascular instability (possibly related to the aftermath of the autonomic storm); prior knowledge that the family would not wish to consider organ donation; and anxieties over the applicability of brainstem death testing in the light of residual sedation or biochemical abnormalities. The
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On-going audit Taskforce recommends that brainstem tests should be performed in all appropriate patients, not just because they might become an organ donor, but because this is in that patient' s best interests. This recommendation does not represent new ground but merely reiterates existing professional advice. For example, the Intensive Care Society' s own guidance states that the certification of death by brainstem testing is important in its own right and "independent of any subsequent consideration of organ donation." 6
Donor transplant coordinators
At present there are around 100 DTCs in the UK working in 18 teams with the majority employed within acute NHS Trusts, often within transplant units. There are also increasing numbers of newly appointed 'in-house coordinators,' fully trained DTCs who are based full-time within a single critical care unit or Trust. The UK system is widely recognised as unsatisfactory and contrasts unfavourably with the Spanish model in which systematic donor coordination is core to success. The Taskforce therefore recommends that the current network of DTCs should be expanded and strengthened through central employment by the UK-wide ODO. Additional coordinators, embedded within critical care areas or within a network of critical care units, should be employed to ensure a comprehensive, highly skilled, specialised and robust service. There should be a close and defined collaboration between DTCs and clinical staff and more formal integration of DTCs into ICU teams, also utilising their skills in areas other than organ donation (e.g. bereavement counselling). Furthermore, to streamline the management of organ donation, it is recommended that more than one DTC will attend each donation and that electronic on-line donor registration and organ offering systems should be established.
Organ retrieval teams
A UK-wide network of dedicated organ retrieval teams should be established to ensure timely, high-quality organ retrieval from all organ donors. The recommendation that these teams should be self-sufficient and not depend on staff from referring hospitals is a welcome one.
Miscellaneous
All clinical staff likely to be involved in the treatment of potential organ donors should receive training in the principles of donation, including regular update training. Organ donation should also be included in undergraduate curricula. The Taskforce also recommends that a method to recognise appropriately the gift of organ donation (perhaps in the form of a national memorial such as the one recently commissioned in Wales) should be established; that the means by which organ donation can be promoted to the general public and particularly to the black and minority ethnic population should be identified and implemented; and that formal guidelines for coroners concerning organ donation should be developed.
Presumed consent
Consideration of presumed consent was precluded from the original discussions of the Taskforce because the terms of reference specifically required all recommendations to be accommodated within existing legal frameworks. However, since the Taskforce began its work there have been statements from the Chief Medical Officer and Prime Minister regarding presumed consent and this issue is now firmly back on the agenda. In a recent article in the Sunday Telegraph the Prime Minister called for a wide public debate about presumed consent, adding that a different consent system could "serve to increase donation levels significantly." 7 Many patient groups oppose a move to presumed consent and, despite support from some areas of the medical profession such as the British Medical Association, there is considerable uncertainty in other quarters that a change in the consent arrangements would actually bring the increases in organ donor numbers that some suggest. In order to inform this debate, the Secretary of State for Health has asked the Organ Donation Taskforce to begin consulting on the question of moving to a different consent system. The Taskforce has established several working groups to examine the issues in detail and the 'clinical' group will be consulting widely with colleagues working in critical care via the Intensive Care Society and the relevant Royal Colleges. The Taskforce has been asked to report to the Secretary of State by summer this year but, whatever the conclusions, the issue of presumed consent must not be allowed to divert attention away from the other changes that are so urgently required to improve organ donation arrangements in the UK.
Conclusion
The 14 recommendations of the Taskforce, taken together, represent a structured and systematic approach to organ donation in the UK. These recommendations are radical and wide-ranging and the involvement of all key stakeholders is essential to their successful implementation. The Taskforce believes that their implementation will save the lives of at least 1,000 patients each year and dramatically improve the quality of life for hundreds more. The three fundamentals: donor identification and referral; donor co-ordination; and organ retrieval, need to be addressed in an integrated way. The proposed changes will ensure that organ donation is considered every time a potential organ donor dies, that the wishes of the potential organ donor or their family are ascertained and respected and that every opportunity is taken to maximise the number of organs that can be transplanted successfully. Furthermore, clarification of legal and ethical issues will allow clinicians to embrace these changes with confidence. Each of the recommendations has an important contribution to make in building the organ donation service that is so urgently needed in the UK and each of us has a part to play in their implementation.
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